Evidence map›Paper›PMID 34297819›Full record

ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2021

Adjunctive surgery versus medical treatment among patients with cavitary multidrug-resistant tuberculosis.

Sergo A Vashakidze, Shota G Gogishvili, Ketino G Nikolaishvili, Zaza R Avaliani, Abivarma Chandrakumaran, Giorgi Sh Gogishvili, Mathew Magee, Henry M Blumberg, Russell R Kempker

Open access · bronzeAbstract read
In one paragraph

Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sergo A VashakidzeThoracic Surgery Department, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Shota G GogishviliThoracic Surgery Department, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Ketino G NikolaishviliThoracic Surgery Department, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Zaza R AvalianiThoracic Surgery Department, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Abivarma ChandrakumaranTbilisi State Medical University, Tbilisi, Georgia.
Giorgi Sh GogishviliThoracic Surgery Department, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Mathew MageeHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Henry M BlumbergDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia Emory University, Atlanta, GA, USA.ORCID 0000-0002-3110-2443
Russell R KempkerDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia Emory University, Atlanta, GA, USA.ORCID 0000-0002-7188-4996
National Center for Tuberculosis and Lung Disease · GEEmory University · USTbilisi State Medical University · GE

Funding

Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary TuberculosisK23AI103044 · NIAID · EMORY UNIVERSITY · PI KEMPKER, RUSSELL RYAN · 2013 to 2017
$910k
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosisR21TW011157 · FIC · NATIONAL CENTER FOR TUBERCULOSIS AND LUNG DISEASES JSC(JOINT STOCK COMPANY) · PI KIPIANI, MAIA, MAGEE, MATTHEW JAMES · 2019 to 2020
$362k
FIC NIH HHS D43 TW007124FIC NIH HHS R21 TW011157NIAID NIH HHS K23 AI103044
6 · The paper itself

Abstract

objectivesSurgical resection is recommended as adjunctive treatment for multidrug-resistant (MDR) tuberculosis (TB) in certain scenarios; however, data are limited. We sought to evaluate the impact of surgery by comparing TB outcomes among patients with cavitary disease who received medical versus combined medical and surgical treatment.

methodsA cohort of all patients with cavitary MDR or extensively drug-resistant (XDR) TB treated in Tbilisi, Georgia, between 2008 and 2012. Patients meeting indications for surgery underwent adjunctive resection in addition to medical treatment. We compared TB outcomes (proportions achieving cure/complete) among patients who received adjunctive surgery to those who received medical treatment alone using an adjusted robust Poisson regression.

resultsAmong 408 patients, 299 received medical treatment alone and 109 combined medical and surgical treatment. Patients in the non-surgical group were older and had higher rates of tobacco and alcohol use and bilateral disease compared to the surgical group. Patients in the surgical group had higher rates of XDR disease (28% vs 15%). Favourable outcomes were higher among the surgical versus non-surgical group cohort (76% vs 41%). After adjusting for multiple factors, the association between adjunctive resection and favourable outcome remained (adjusted risk ratio 1.6, 95% confidence interval 1.3-2.0); the relationship was also observed in secondary models that excluded patients with bilateral disease (contraindication for surgery) and patients receiving <6 months of treatment. Major postoperative complications occurred among 8 patients (7%) with no postoperative mortality.

conclusionsAdjunctive surgery is safe and may improve the effectiveness of treatment among select patients with cavitary MDR- and XDR-TB.

Indexed as

Tuberculosis, Multidrug-ResistantTuberculosis, PulmonaryHumansPneumonectomyRetrospective StudiesTreatment OutcomeCavitaryDrug resistancePulmonary tuberculosisSurgical resection

Identifiers

PMID34297819
PMCPMC8643477
OpenAlexW3184924095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.